在人类肝脏显微体中,苏博洛辛对CYP1A2的选择性抑制作用
Sanjita Paudel1, Hyoje Jo1, Taeho Lee1
1BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Biopharmaceutics & drug disposition
|July 14, 2023
概括
苏贝罗辛是Citropsis articulata中的一种化合物,可以选择性地抑制细胞染色体P450 1A2 (CYP1A2). 这表明,当与由CYP1A2.2.代谢的药物一起服用时,可能存在草药相互作用.
科学领域:
- 药理学 药理学 是一个学科.
- 自然产品 化学 化学
背景情况:
- 苏贝罗辛是一种来自Citropsis articulata的植物成分,具有抗凝固特性.
- 之前对苏贝罗辛的代谢研究已经存在,但其对药物和食物相互作用的潜力仍未得到充分探索.
研究的目的:
- 为了研究苏博洛辛对细胞P450 (CYP) 酶的选择性抑制作用.
- 为了确定suberosin与CYP酶相互作用的机制.
主要方法:
- 采用尾酒探针测定方法,使用各种度的苏博洛辛 (0-50μM),在人类肝脏显微体 (HLM) 中与异形特异性CYP探针进行化.
- 使用Lineweaver-Burk图分析了酶动力学.
- 抑制研究还对复合人类CYP1A1和1A2.2进行了研究.
主要成果:
- 苏贝罗辛显著抑制了由CYP1A2催化的甲O脱乙化,其IC50值为9.39 ± 2.05μM (预化) 和3.07 ± 0.45μM (没有预化).
- 抑制是度依赖的,但不是时间依赖的,表明suberosin是一种可逆CYP1A2抑制剂和基质.
- 在Lineweaver-Burk分析中,发现CYP1A2的竞争性抑制.
- 在复合CYP1A1和1A2.2上观察到类似的抑制作用.
结论:
- 苏贝罗辛选择性地抑制CYP1A2,作为一种竞争性和可逆性抑制剂.
- 这些发现表明,suberosin有可能导致与同时服用CYP1A2基质的草药相互作用.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
158
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
158
Hepatic Drug Excretion: Enterohepatic Cycling
1.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K
Enzyme Inhibition
78.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.8K
Hepatic Drug Clearance: Role of Transporters
87
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
87
First Pass Effect
5.7K
Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
5.7K
The Electron Transport Chain
17.0K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.0K


